Sifted Studio
Sifted Studio
Podcast Description
Podcasts produced by Sifted Studio, the award-nominated content studio within Sifted, in collaboration with trusted partners.
Podcast Insights
Content Themes
Topics explored in the podcasts include responsible AI adoption, Europe's AI potential, innovation in pharmaceuticals through AI, operating startups during economic downturns, and lessons from past financial crises. For example, episodes discuss AI's impact on drug development, with insights from leaders in pharma like Sanofi, and strategies for navigating difficult times from experienced entrepreneurs.
Podcasts produced by Sifted Studio, the award-nominated content studio within Sifted, in collaboration with trusted partners.
Europe's AI opportunity is a new podcast mini-series is brought to you by Sifted and Nebius, an AI infrastructure company building full-stack cloud for the AI era.
Over the next three episodes, Sifted's senior reporter Daphné Leprince-Ringuet will be exploring the potential of AI for Europe's enterprises.
This episode was recorded live from VivaTech in Paris — France’s flagship tech event that brings together startups, corporates and industrial leaders.
This episode focuses on whether, and how, European enterprises are adopting AI, and what this means for the AI startups they partner with — or, in some cases, don’t.
Joining the conversation were Claire Nouet, cofounder and COO of Pathway, Olivier Gomez, cofounder and CEO of IAC.AI, and Anubhav Maheshwari, head of venture partnerships at Nebius.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.